Buchumschlag

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Alisa Bannerjee, Wendy Elkins, Susan M. Resnick, Murat Bilgel
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
von: Stefan J. Teipel, et al.
Veröffentlicht: (2024)

Marital dissolution and cognition: The mediating effect of Aβ neuropathology
von: Avinash Chandra, et al.
Veröffentlicht: (2024)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
von: Rosanne L. van den Berg, et al.
Veröffentlicht: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
von: Kevin Duff, et al.
Veröffentlicht: (2024)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
von: Rachel R. Jin, et al.
Veröffentlicht: (2025)

Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive decline
von: Ismael L. Calandri, et al.
Veröffentlicht: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
von: Sofia Toniolo, et al.
Veröffentlicht: (2024)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
von: Frederikke Kragh Clemmensen, et al.
Veröffentlicht: (2026)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
von: Ying Xia, et al.
Veröffentlicht: (2025)

Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease
von: R. Asaad Baksh, et al.
Veröffentlicht: (2024)

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
von: Caitlin M. Terao, et al.
Veröffentlicht: (2025)

Gender differences in cognitive reserve: An impact on progression in subjective cognitive decline?
von: Giulia Giacomucci, et al.
Veröffentlicht: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
von: María A. Rodríguez‐Santiago, et al.
Veröffentlicht: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
von: Lars Frings, et al.
Veröffentlicht: (2025)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
von: David Foxe, et al.
Veröffentlicht: (2024)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
von: Willa D. Brenowitz, et al.
Veröffentlicht: (2026)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
von: Alexandra Paget‐Blanc, et al.
Veröffentlicht: (2025)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
von: Zheng Long Lee, et al.
Veröffentlicht: (2026)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
von: Jacqueline Chua, et al.
Veröffentlicht: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
von: Miguel Ángel Rivas‐Fernández, et al.
Veröffentlicht: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
von: Ihab Hajjar, et al.
Veröffentlicht: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
von: Juliana N. Souza‐Talarico, et al.
Veröffentlicht: (2025)

Detecting time‐varying genetic effects in Alzheimer's disease using a longitudinal genome‐wide association studies model
von: Xiaowei Zhuang, et al.
Veröffentlicht: (2024)

Association of apolipoprotein E genotype with cognitive performance: findings from the University of California, Davis Alzheimer's Disease Research Center longitudinal diversity cohort
von: Eva Min, et al.
Veröffentlicht: (2026)

Lower odor identification in subjective cognitive decline: a meta‐analysis
von: Benoît Jobin, et al.
Veröffentlicht: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
von: Sunu Mathew, et al.
Veröffentlicht: (2025)

Delayed primacy recall performance predicts post mortem Alzheimer's disease pathology from unimpaired ante mortem cognitive baseline
von: Davide Bruno, et al.
Veröffentlicht: (2024)

Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteria
von: Leonardo E. Ariello, et al.
Veröffentlicht: (2025)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
von: Xiang‐Sha Yin, et al.
Veröffentlicht: (2025)

Blood biomarkers for Alzheimer's disease: Reliable change and impacts of renal and blood–brain barrier function
von: Anders Behrens, et al.
Veröffentlicht: (2025)

Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging
von: Yuxin Li, et al.
Veröffentlicht: (2026)

A systematic review and meta‐analysis of basal microbiota and cognitive function in Alzheimer's disease: A potential target for treatment or a contributor to disease progression?
von: Ana Maria Jimenez‐García, et al.
Veröffentlicht: (2024)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
von: Gustavo Luis Verón, et al.
Veröffentlicht: (2025)

A systematic review and meta‐analysis of dual‐task outcomes in subjective cognitive decline
von: Talia Salzman, et al.
Veröffentlicht: (2025)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
von: Jessie T. Yan, et al.
Veröffentlicht: (2025)

The relative contribution of modifiable and non‐modifiable factors for determining cognition in mid‐life individuals at risk for late‐life Alzheimer's disease
von: Bolin Cao, et al.
Veröffentlicht: (2026)

Accuracy of pattern‐based dementia diagnostic protocols: Using longitudinal data to infer etiology of Alzheimer's disease and related dementias compared to stroke or normal aging
von: Sean A. P. Clouston, et al.
Veröffentlicht: (2025)

Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis
von: Annibale Antonioni, et al.
Veröffentlicht: (2025)

Influence of cognitive, neuropsychiatric, and diagnostic factors on financial capacity: A longitudinal analysis of the ADNI cohort
von: Milap A. Nowrangi, et al.
Veröffentlicht: (2025)

Procrastination as a marker of cognitive decline: Evidence from longitudinal transitions in the older adult population
von: Cormac Monaghan, et al.
Veröffentlicht: (2026)